{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:21:24Z","timestamp":1788366084960,"version":"build-2803163510"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Medical Research Council Transition Award","award":["TA24jul-0008"],"award-info":[{"award-number":["TA24jul-0008"]}]},{"name":"CSDU Clinician-Scientist Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"DOI":"10.1007\/s00392-026-03010-5","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:31:06Z","timestamp":1788359466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Body composition phenotypes are key predictors of cardiovascular-kidney-metabolic multimorbidity and long-term mortality: insights from a population-based cohort study"],"prefix":"10.1007","author":[{"given":"Gwyneth","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Made Ayu Utami","family":"Intaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest Su Wei","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalkin","family":"Yazicioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinithy","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel W.","family":"le Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamas A.","family":"Mamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0640-0430","authenticated-orcid":false,"given":"Nicholas W. S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"3","key":"3010_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jacc.2025.04.061","volume":"86","author":"B Chong","year":"2025","unstructured":"Chong B, Jayabaskaran J, Jauhari SM et al (2025) The global syndemic of modifiable cardiovascular risk factors projected from 2025 to 2050. J Am Coll Cardiol 86(3):165\u2013177","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3010_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41569-025-01220-4","volume":"23","author":"NWS Chew","year":"2025","unstructured":"Chew NWS, Mehta A, Goh R et al (2025) The global cardiovascular-liver-metabolic syndemic: epidemiology, trends and challenges. Nat Rev Cardiol 23(4):219\u2013238","journal-title":"Nat Rev Cardiol"},{"issue":"10431","key":"3010_CR3","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NH Phelps","year":"2024","unstructured":"Phelps NH, Singleton RK, Zhou B et al (2024) Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 403(10431):1027\u20131050","journal-title":"Lancet"},{"key":"3010_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102848","author":"X-D Zhou","year":"2021","unstructured":"Zhou X-D, Chen Q-F, Yang W et al (2021) Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021. EClinicalMedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102848","journal-title":"EClinicalMedicine"},{"issue":"21","key":"3010_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.043629","volume":"14","author":"CY Koo","year":"2021","unstructured":"Koo CY, Chong B, Jayabaskaran J et al (2021) Global trends and forecast of cardiovascular diseases, cancer, and shared risk factors: insights from the GBD 2021. J Am Heart Assoc 14(21):e043629","journal-title":"J Am Heart Assoc"},{"key":"3010_CR6","unstructured":"Goh LH, Chong B, Lubbe SCCvd et al (2025) The epidemiology and burden of cardiovascular diseases in countries of the Association of Southeast Asian Nations (ASEAN), 1990\u20132021: findings from the Global Burden of Disease Study 2021. Lancet Public Health 10(6)"},{"key":"3010_CR7","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2021.20410","author":"J Cawley","year":"2021","unstructured":"Cawley J, Biener A, Meyerhoefer C et al (2021) Direct medical costs of obesity in the United States and the most populous states. J Manag Care Spec Pharm. https:\/\/doi.org\/10.18553\/jmcp.2021.20410","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"3010_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-113719","volume":"16","author":"MTW Kueh","year":"2026","unstructured":"Kueh MTW, Intaran MAU, Goh R et al (2026) Body weight categories and fat distribution in relation to all-cause mortality among adults with metabolic dysfunction-associated steatotic liver disease: a population-based analysis of NHANES, 2007\u20132018. BMJ Open 16(6):e113719","journal-title":"BMJ Open"},{"issue":"3","key":"3010_CR9","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/oby.23658","volume":"31","author":"G Kong","year":"2023","unstructured":"Kong G, Chin YH, Lim J et al (2023) A two-decade population-based study on the effect of hypertension in the general population with obesity in the United States. Obesity (Silver Spring, Md.) 31(3):832\u2013840","journal-title":"Obesity (Silver Spring, Md.)"},{"key":"3010_CR10","first-page":"100803","volume":"37","author":"NWS Chew","year":"2023","unstructured":"Chew NWS, Chong B, Kuo SM et al (2023) Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort. Lancet Reg Health West Pac 37:100803","journal-title":"Lancet Reg Health West Pac"},{"issue":"4","key":"3010_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11886-024-02025-6","volume":"26","author":"ECZ Lee","year":"2024","unstructured":"Lee ECZ, Anand VV, Razavi AC et al (2024) The global epidemic of metabolic fatty liver disease. Curr Cardiol Rep 26(4):199\u2013210","journal-title":"Curr Cardiol Rep"},{"key":"3010_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.869168","volume":"9","author":"G Kong","year":"2022","unstructured":"Kong G, Chew NWS, Ng CH et al (2022) Prognostic outcomes in acute myocardial infarction patients without standard modifiable risk factors: a multiethnic study of 8,680 Asian patients. Front Cardiovasc Med 9:869168","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"3010_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","volume":"22","author":"M Marassi","year":"2023","unstructured":"Marassi M, Fadini GP (2023) The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol 22(1):195","journal-title":"Cardiovasc Diabetol"},{"key":"3010_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001645","author":"X-D Zhou","year":"2025","unstructured":"Zhou X-D, Chen Q-F, Fan Q-Y et al (2025) Cardiovascular-kidney-metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD. Hepatology. https:\/\/doi.org\/10.1097\/hep.0000000000001645","journal-title":"Hepatology"},{"key":"3010_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.101405","author":"Y Chen","year":"2026","unstructured":"Chen Y, Himan HR, Yazicioglu Y et al (2026) Population estimates, trends, characteristics and prognostic outcomes of cardiovascular-kidney-liver-metabolic health: a population-based study. Am J Prev Cardiol. https:\/\/doi.org\/10.1016\/j.ajpc.2025.101405","journal-title":"Am J Prev Cardiol"},{"issue":"19","key":"3010_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.041834","volume":"14","author":"RSJ Goh","year":"2025","unstructured":"Goh RSJ, Koh J, Intaran MAU et al (2025) Population-based study on the coexistence of metabolic dysfunction-associated steatotic liver disease and chronic kidney disease. J Am Heart Assoc 14(19):e041834","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3010_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","volume":"151","author":"NWS Chew","year":"2025","unstructured":"Chew NWS, Mehta A, Goh RSJ et al (2025) Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified Delphi Approach. Circulation 151(1):98\u2013119","journal-title":"Circulation"},{"issue":"20","key":"3010_CR18","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR et al (2023) A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation 148(20):1636\u20131664","journal-title":"Circulation"},{"key":"3010_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12872-025-04910-6","volume":"25","author":"S Zhao","year":"2025","unstructured":"Zhao S, Liu H, Liu A (2025) Associations of cardiovascular-kidney-metabolic conditions with all-cause and cardiovascular mortality among US adults: a population-based cohort study. BMC Cardiovasc Disord 25:443","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"3010_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70747","volume":"46","author":"MT Kueh","year":"2026","unstructured":"Kueh MT, Yeo JKW, Chen Y et al (2026) Global prevalence, incidence, and outcomes of coexisting MASLD and chronic kidney disease: a meta\u2010analysis. Liver Int 46(7):e70747","journal-title":"Liver Int"},{"issue":"21","key":"3010_CR21","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2011","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M (2011) Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020. JAMA 331(21):1858\u20131860","journal-title":"JAMA"},{"issue":"3","key":"3010_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.soard.2024.10.038","volume":"21","author":"J Carter","year":"2025","unstructured":"Carter J, Husain F, Papasavas P et al (2025) American Society for Metabolic and Bariatric Surgery review of the body mass index. Surg Obes Relat Dis 21(3):199\u2013206","journal-title":"Surg Obes Relat Dis"},{"issue":"18","key":"3010_CR23","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1161\/CIR.0b013e318233bc6a","volume":"124","author":"M-A Cornier","year":"2011","unstructured":"Cornier M-A, Despr\u00e9s J-P, Davis N et al (2011) Assessing adiposity: a scientific statement from the American Heart Association. Circulation 124(18):1996\u20132019","journal-title":"Circulation"},{"issue":"8","key":"3010_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jacc.2008.03.066","volume":"52","author":"RP Gelber","year":"2008","unstructured":"Gelber RP, Gaziano JM, Orav EJ, Manson JE, Buring JE, Kurth T (2008) Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 52(8):605\u2013615","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3010_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","volume":"13","author":"M Ashwell","year":"2012","unstructured":"Ashwell M, Gunn P, Gibson S (2012) Waist\u2010to\u2010height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta\u2010analysis. Obes Rev 13(3):275\u2013286","journal-title":"Obes Rev"},{"issue":"1","key":"3010_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep43046","volume":"7","author":"S Shen","year":"2017","unstructured":"Shen S, Lu Y, Qi H et al (2017) Waist-to-height ratio is an effective indicator for comprehensive cardiovascular health. Sci Rep 7(1):43046","journal-title":"Sci Rep"},{"key":"3010_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.971484","volume":"13","author":"NWS Chew","year":"2022","unstructured":"Chew NWS, Chong B, Ng CH et al (2022) The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases. Front Genet 13:971484","journal-title":"Front Genet"},{"issue":"4","key":"3010_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.122.009340","volume":"16","author":"G Kong","year":"2023","unstructured":"Kong G, Zhang A, Chong B (2023) Long-term prognosis of patients with coexisting obesity and malnutrition after acute myocardial infarction: a cohort study. Circ Cardiovasc Qual Outcomes 16(4):e009340","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"3010_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-02646-1","volume":"22","author":"S Zhang","year":"2022","unstructured":"Zhang S, Fu X, Du Z et al (2022) Is waist-to-height ratio the best predictive indicator of cardiovascular disease incidence in hypertensive adults? A cohort study. BMC Cardiovasc Disord 22(1):214","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"3010_CR30","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1365-2796.2006.01706.x","volume":"260","author":"M Lu","year":"2006","unstructured":"Lu M, Ye W, Adami HO, Weiderpass E (2006) Prospective study of body size and risk for stroke amongst women below age 60. J Intern Med 260(5):442\u2013450","journal-title":"J Intern Med"},{"issue":"3","key":"3010_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH et al (2025) Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol 13(3):221\u2013262","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3010_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pcad.2025.12.004","volume":"94","author":"PL Alebna","year":"2025","unstructured":"Alebna PL, Ambrosio M, Dod R et al (2025) Evaluation of the PREVENT risk assessment tool and visceral adiposity: insights from the UK Biobank. Prog Cardiovasc Dis 94:56\u201362","journal-title":"Prog Cardiovasc Dis"},{"issue":"9403","key":"3010_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403):157\u2013163","journal-title":"Lancet"},{"issue":"3","key":"3010_CR34","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s13679-024-00580-1","volume":"13","author":"K Sweatt","year":"2024","unstructured":"Sweatt K, Garvey WT, Martins C (2024) Strengths and limitations of bmi in the diagnosis of obesity: what is the path forward? Curr Obes Rep 13(3):584\u2013595","journal-title":"Curr Obes Rep"},{"issue":"10","key":"3010_CR35","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.cgh.2022.11.019","volume":"21","author":"J Ha","year":"2023","unstructured":"Ha J, Yim SY, Karagozian R (2023) Mortality and liver-related events in lean versus non-lean nonalcoholic fatty liver disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 21(10):2496-2507.e5","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"3010_CR36","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1111\/dom.14820","volume":"24","author":"NW Chew","year":"2022","unstructured":"Chew NW, Figtree GA, Kong G (2022) Hepatic steatosis and advanced fibrosis are independent predictors of mortality in acute myocardial infarction without standard modifiable risk factors. Diabetes Obes Metab 24(12):2454\u20132458","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"3010_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12916-023-02891-x","volume":"21","author":"TJ Hydes","year":"2023","unstructured":"Hydes TJ, Kennedy OJ, Buchanan R (2023) The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank. BMC Med 21(1):185","journal-title":"BMC Med"},{"key":"3010_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111652","volume":"211","author":"NWS Chew","year":"2024","unstructured":"Chew NWS, Pan XH, Chong B et al (2024) Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population. Diabetes Res Clin Pract 211:111652","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"3010_CR39","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/apt.17397","volume":"57","author":"CE Fu","year":"2023","unstructured":"Fu CE, Yong JN, Ng CH et al (2023) The prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndrome. Aliment Pharmacol Ther 57(9):979\u2013987","journal-title":"Aliment Pharmacol Ther"},{"key":"3010_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.942753","volume":"9","author":"CH Ng","year":"2022","unstructured":"Ng CH, Wong ZY, Chew NWS et al (2022) Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality. Front Cardiovasc Med 9:942753","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"3010_CR41","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.00499.2025","volume":"330","author":"S Gunnarsson","year":"2025","unstructured":"Gunnarsson S, Vito O, Unwin RJ (2025) Cardiovascular-kidney-metabolic (CKM) syndrome: prevalence, risks, disease trajectories, and early-stage management. Am J Physiol Cell Physiol 330(1):C1\u2013C8","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"3010_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11239-022-02704-7","volume":"54","author":"G Kong","year":"2022","unstructured":"Kong G, Chew NWS, Ng CH et al (2022) Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study of 5400 asian patients. J Thromb Thrombolysis 54(4):569\u2013578","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"3010_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.eprac.2022.10.007","volume":"29","author":"CE Fu","year":"2023","unstructured":"Fu CE, Ng CH, Yong JN et al (2023) A meta-analysis on associated risk of mortality in nonalcoholic fatty liver disease. Endocr Pract 29(1):33\u201339","journal-title":"Endocr Pract"},{"issue":"10","key":"3010_CR44","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1016\/j.cgh.2022.09.028","volume":"21","author":"KE Chan","year":"2023","unstructured":"Chan KE, Ng CH, Fu CE et al (2023) The spectrum and impact of metabolic dysfunction in MAFLD: a longitudinal cohort analysis of 32,683 overweight and obese individuals. Clin Gastroenterol Hepatol 21(10):2560-2569.e15","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"3010_CR45","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","volume":"132","author":"M Burnier","year":"2023","unstructured":"Burnier M, Damianaki A (2023) Hypertension as cardiovascular risk factor in chronic kidney disease. Circ Res 132(8):1050\u20131063","journal-title":"Circ Res"},{"key":"3010_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.949260","volume":"13","author":"OZ Ameer","year":"2022","unstructured":"Ameer OZ (2022) Hypertension in chronic kidney disease: what lies behind the scene. Front Pharmacol 13:949260","journal-title":"Front Pharmacol"},{"issue":"16","key":"3010_CR47","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032671","volume":"13","author":"N Weight","year":"2024","unstructured":"Weight N, Moledina S, Ullah M et al (2024) Impact of chronic kidney disease on the processes of care and long-term mortality of non\u2013ST-segment\u2013elevation myocardial infarction: a nationwide cohort study and long-term follow-up. J Am Heart Assoc 13(16):e032671","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"3010_CR48","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1111\/dom.15660","volume":"26","author":"G Kong","year":"2024","unstructured":"Kong G, Cao G, Koh J et al (2024) The prognostic value of metabolic dysfunction-associated steatotic liver disease in acute myocardial infarction: a propensity score-matched analysis. Diabetes Obes Metab 26(8):3328\u20133338","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"3010_CR49","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/dom.16062","volume":"27","author":"J Koh","year":"2025","unstructured":"Koh J, Mohamed A, Kong G et al (2025) Long-term all-cause mortality of metabolic-dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: a retrospective cohort study. Diabetes Obes Metab 27(2):683\u2013696","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"3010_CR50","first-page":"1220","volume":"38","author":"NW Chew","year":"2022","unstructured":"Chew NW, Zhang A, Ong J et al (2022) Long-term prognosis in patients with concomitant acute coronary syndrome and aortic stenosis. Can J Cardiol 38(8):1220\u20131227","journal-title":"Can J Cardiol"},{"issue":"9","key":"3010_CR51","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/apt.17397","volume":"57","author":"CE Fu","year":"2023","unstructured":"Fu CE, Yong JN, Ng CH et al (2023) The prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndrome. Aliment Pharmacol Ther 57(9):979\u2013987","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl_1","key":"3010_CR52","doi-asserted-by":"publisher","first-page":"A4141831","DOI":"10.1161\/circ.150.suppl_1.4141831","volume":"150","author":"J Ostrominski","year":"2024","unstructured":"Ostrominski J, Hirsch J, Miao B et al (2024) Estimating time to incidence and progression of cardiovascular-kidney-metabolic multimorbidity: a large-scale longitudinal cohort study. Circulation 150(Suppl_1):A4141831\u2013A4141831","journal-title":"Circulation"},{"issue":"7","key":"3010_CR53","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11883-022-01027-5","volume":"24","author":"NWS Chew","year":"2022","unstructured":"Chew NWS, Ng CH, Muthiah MD, Sanyal AJ (2022) Comprehensive review and updates on holistic approach towards non-alcoholic fatty liver disease management with cardiovascular disease. Curr Atheroscler Rep 24(7):515\u2013532","journal-title":"Curr Atheroscler Rep"},{"key":"3010_CR54","doi-asserted-by":"publisher","DOI":"10.2196\/46036","volume":"26","author":"HS Chew","year":"2024","unstructured":"Chew HS, Chew NW, Loong SS et al (2024) Effectiveness of an artificial intelligence-assisted app for improving eating behaviors: mixed methods evaluation. J Med Internet Res 26:e46036","journal-title":"J Med Internet Res"},{"issue":"5","key":"3010_CR55","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.eprac.2022.10.006","volume":"29","author":"VV Anand","year":"2023","unstructured":"Anand VV, Zhe ELC, Chin YH et al (2023) Barriers and facilitators to engagement with a weight management intervention in Asian patients with overweight or obesity: a systematic review. Endocr Pract 29(5):398\u2013407","journal-title":"Endocr Pract"},{"issue":"1","key":"3010_CR56","doi-asserted-by":"publisher","first-page":"26499","DOI":"10.1038\/s41598-025-12583-6","volume":"15","author":"E Wong","year":"2025","unstructured":"Wong E, Chen Y, Kong G et al (2025) Non-invasive scoring systems of liver fibrosis predict prognosis in the cohort with myocardial infarction. Sci Rep 15(1):26499","journal-title":"Sci Rep"},{"issue":"1","key":"3010_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/oby.23600","volume":"31","author":"DC Llewellyn","year":"2023","unstructured":"Llewellyn DC, Logan Ellis H, Aylwin SJB et al (2023) The efficacy of GLP-1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review. Obesity (Silver Spring) 31(1):20\u201330","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"3010_CR58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12933-025-02840-3","volume":"24","author":"ASP Tang","year":"2025","unstructured":"Tang ASP, Hsu JTY, Chong SKS et al (2025) Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety. Cardiovasc Diabetol 24(1):285","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"3010_CR59","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/ehf2.13822","volume":"9","author":"T Yeong","year":"2022","unstructured":"Yeong T, Mai AS, Lim OZH et al (2022) Can glucose-lowering medications improve outcomes in non-diabetic heart failure patients? A Bayesian network meta-analysis. ESC Heart Fail 9(2):1338\u20131350","journal-title":"ESC Heart Fail"},{"issue":"3","key":"3010_CR60","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1055\/a-1877-9656","volume":"42","author":"NWS Chew","year":"2022","unstructured":"Chew NWS, Ng CH, Truong E, Noureddin M, Kowdley KV (2022) Nonalcoholic steatohepatitis drug development pipeline: an update. Semin Liver Dis 42(3):379\u2013400","journal-title":"Semin Liver Dis"},{"issue":"2","key":"3010_CR61","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/ehf2.13822","volume":"9","author":"T Yeong","year":"2022","unstructured":"Yeong T, Mai AS, Lim OZ et al (2022) Can glucose\u2010lowering medications improve outcomes in non\u2010diabetic heart failure patients? A Bayesian network meta\u2010analysis. ESC Heart Fail 9(2):1338\u20131350","journal-title":"ESC Heart Fail"},{"issue":"11","key":"3010_CR62","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/nutrit\/nuad163","volume":"82","author":"HSJ Chew","year":"2024","unstructured":"Chew HSJ, Soong RY, Teo YQJ et al (2024) Anthropometric and cardiometabolic effects of polyphenols in people with overweight and obesity: an umbrella review. Nutr Rev 82(11):1556\u20131593","journal-title":"Nutr Rev"},{"issue":"8","key":"3010_CR63","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13759","volume":"25","author":"F Lajeunesse\u2010Trempe","year":"2024","unstructured":"Lajeunesse\u2010Trempe F, Okroj D, Ostarijas E et al (2024) Medication and supplement pharmacokinetic changes following bariatric surgery: a systematic review and meta\u2010analysis. Obes Rev 25(8):e13759","journal-title":"Obes Rev"},{"issue":"2","key":"3010_CR64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.eprac.2021.09.013","volume":"28","author":"CH Ng","year":"2022","unstructured":"Ng CH, Lin SY, Chin YH et al (2022) Antidiabetic medications for type 2 diabetics with nonalcoholic fatty liver disease: evidence from a network meta-analysis of randomized controlled trials. Endocr Pract 28(2):223\u2013230","journal-title":"Endocr Pract"},{"issue":"1","key":"3010_CR65","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/oby.23600","volume":"31","author":"DC Llewellyn","year":"2023","unstructured":"Llewellyn DC, Logan Ellis H, Aylwin SJ et al (2023) The efficacy of GLP\u20101RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review. Obesity Silver Spring 31(1):20\u201330","journal-title":"Obesity Silver Spring"},{"key":"3010_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101685","volume":"54","author":"YH Chin","year":"2022","unstructured":"Chin YH, Ng CH, Chew NW et al (2022) The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis. EClinicalMedicine\u00a0 54:101685","journal-title":"EClinicalMedicine\u00a0"},{"issue":"5","key":"3010_CR67","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/ehjqcco\/qcac060","volume":"9","author":"YH Chin","year":"2023","unstructured":"Chin YH, Lim O, Lin C et al (2023) Meta-analysis of the placebo and nocebo effects associated with placebo treatment in randomized trials of lipid-lowering therapies. Eur Heart J Qual Care Clin Outcomes 9(5):511\u2013519","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"3010_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2026.101902","author":"NW Chew","year":"2026","unstructured":"Chew NW, Kong G, Cader FA et al (2026) Systematic review of cardiovascular care delivery across health systems in the Asia\u2013Pacific: a regional roadmap for strengthening cardiovascular care. Lancet Reg Health West Pac. https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101902","journal-title":"Lancet Reg Health West Pac"},{"issue":"4","key":"3010_CR69","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41569-025-01220-4","volume":"23","author":"NW Chew","year":"2026","unstructured":"Chew NW, Mehta A, Goh R et al (2026) The global cardiovascular\u2013liver\u2013metabolic syndemic: epidemiology, trends and challenges. Nat Rev Cardiol 23(4):219\u2013238","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"3010_CR70","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00392-024-02563-7","volume":"114","author":"VV Anand","year":"2025","unstructured":"Anand VV, Koh J, Teo T et al (2025) Sex differences in survival following acute coronary syndrome with and without standard modifiable risk factors. Clin Res Cardiol 114(6):681\u2013689","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"3010_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02552-0","volume":"24","author":"G Kong","year":"2025","unstructured":"Kong G, Koh J, Chia J et al (2025) A sex-disaggregated analysis of the prognostic value of lean type 2 diabetes mellitus in the adult population with acute myocardial infarction. Cardiovasc Diabetol 24(1):59","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"3010_CR72","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.eprac.2022.05.007","volume":"28","author":"NWS Chew","year":"2022","unstructured":"Chew NWS, Kong G, Venisha S et al (2022) Long-term prognosis of acute myocardial infarction associated with metabolic health and obesity status. Endocr Pract 28(8):802\u2013810","journal-title":"Endocr Pract"},{"key":"3010_CR73","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijcard.2023.04.042","volume":"383","author":"VV Anand","year":"2023","unstructured":"Anand VV, Zhe ELC, Chin YH et al (2023) Socioeconomic deprivation and prognostic outcomes in acute coronary syndrome: a meta-analysis using multidimensional socioeconomic status indices. Int J Cardiol 383:140\u2013150","journal-title":"Int J Cardiol"},{"issue":"5","key":"3010_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177175","volume":"12","author":"MG Swainson","year":"2017","unstructured":"Swainson MG, Batterham AM, Tsakirides C, Rutherford ZH, Hind K (2017) Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables. PloS one 12(5):e0177175","journal-title":"PloS one"},{"key":"3010_CR75","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejim.2023.09.002","volume":"117","author":"G Muscogiuri","year":"2023","unstructured":"Muscogiuri G, Verde L, Colao A (2023) Body mass index (BMI): still be used? Eur J Intern Med 117:50\u201351","journal-title":"Eur J Intern Med"},{"key":"3010_CR76","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70271","author":"LY Lian","year":"2025","unstructured":"Lian LY, Liu C, Zhou XD et al (2025) Newly defined clinical obesity versus body mass index\u2010defined obesity: differential risks of overall death and adverse events in a population\u2010based cohort. Diabetes Obes Metab. https:\/\/doi.org\/10.1111\/dom.70271","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"3010_CR77","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13098-015-0069-5","volume":"7","author":"SR Millar","year":"2015","unstructured":"Millar SR, Perry IJ, Phillips CM (2015) Assessing cardiometabolic risk in middle-aged adults using body mass index and waist\u2013height ratio: are two indices better than one? A cross-sectional study. Diabetol Metab Syndr 7(1):73","journal-title":"Diabetol Metab Syndr"},{"issue":"20","key":"3010_CR78","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.jacc.2025.08.039","volume":"86","author":"JW Ostrominski","year":"2025","unstructured":"Ostrominski JW, Harrington J, Claggett BL et al (2025) Anthropometric measures, cardiovascular outcomes, and treatment effects of finerenone in cardiovascular-kidney-metabolic disease: pooled participant-level analysis of 3 global trials. J Am Coll Cardiol 86(20):1781\u20131801","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3010_CR79","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/oby.23658","volume":"31","author":"G Kong","year":"2023","unstructured":"Kong G, Chin YH, Lim J et al (2023) A two\u2010decade population\u2010based study on the effect of hypertension in the general population with obesity in the United States. Obesity 31(3):832\u2013840","journal-title":"Obesity"},{"issue":"11","key":"3010_CR80","first-page":"1779","volume":"38","author":"NW Chew","year":"2022","unstructured":"Chew NW, Ng CH, Chan KE et al (2022) FIB-4 predicts MACE and cardiovascular mortality in patients with nonalcoholic fatty liver disease. Can J Cardiol 38(11):1779\u20131780","journal-title":"Can J Cardiol"},{"issue":"20","key":"3010_CR81","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1161\/CIRCULATIONAHA.123.064071","volume":"147","author":"AA Damluji","year":"2023","unstructured":"Damluji AA, Alfaraidhy M, AlHajri N et al (2023) Sarcopenia and cardiovascular diseases. Circulation 147(20):1534\u20131553","journal-title":"Circulation"},{"issue":"17","key":"3010_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14176008","volume":"14","author":"Z Yang","year":"1999","unstructured":"Yang Z, Wu S, Li Y et al (1999) Association of frailty status with staging and mortality risk of cardiovascular-kidney-metabolic syndrome in middle-aged and older populations: insights from the 1999\u20132018 National Health and Nutrition Examination Survey. J Clin Med 14(17):6008","journal-title":"J Clin Med"},{"key":"3010_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2023.02.023","volume":"196","author":"C Lin","year":"2023","unstructured":"Lin C, Loke WH, Ng BH et al (2023) Mortality, cardiovascular, and medication outcomes in patients with myocardial infarction and underweight in a meta-analysis of 6.3 million patients. Am J Cardiol 196:1","journal-title":"Am J Cardiol"},{"issue":"8","key":"3010_CR84","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2337\/dci17-0010","volume":"40","author":"DK Tobias","year":"2017","unstructured":"Tobias DK (2017) Addressing reverse causation bias in the obesity paradox is not \u201cone size fits all.\u201d Diabetes Care 40(8):1000\u20131001","journal-title":"Diabetes Care"},{"issue":"12","key":"3010_CR85","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/eurjpc\/zwad133","volume":"30","author":"CYL Yaow","year":"2023","unstructured":"Yaow CYL, Chong B, Chin YH et al (2023) Higher risk of adverse cardiovascular outcomes in females with type 2 diabetes mellitus: an Umbrella review of systematic reviews. Eur J Prev Cardiol 30(12):1227\u20131235","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"3010_CR86","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/dom.14950","volume":"25","author":"Y Chin","year":"2023","unstructured":"Chin Y, Lim J, Kong G et al (2023) Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long\u2010term mortality in acute myocardial infarction. Diabetes Obes Metab 25(4):1032\u20131044","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"3010_CR87","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jacasi.2026.01.027","volume":"6","author":"G Cao","year":"2026","unstructured":"Cao G, Weight N, Jauhari SM et al (2026) Myocardial infarction without standard modifiable risk factors from 2025\u20132040: forecast analysis of multinational, population-based study. JACC Asia 6(6):910\u2013925","journal-title":"JACC Asia"},{"key":"3010_CR88","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-026-02925-3","author":"A Zhang","year":"2026","unstructured":"Zhang A, Kong G, Cao G et al (2026) Long-term prognosis of coexistent metabolic dysfunction\u2013associated steatotic liver disease and chronic kidney disease following acute myocardial infarction. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-026-02925-3","journal-title":"Clin Res Cardiol"},{"key":"3010_CR89","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-025-02800-7","author":"R Mahesh","year":"2025","unstructured":"Mahesh R, Wong DHC, Anand VV et al (2025) Natural history and outcomes of medically treated coronary artery disease: insights from reconstructed individual patient data of 29 randomized trials. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-025-02800-7","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"3010_CR90","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11883-025-01284-0","volume":"27","author":"MK Campbell","year":"2025","unstructured":"Campbell MK, Chew NW, Mehta A (2025) Beyond cholesterol: unraveling residual lipidomic risk in cardiovascular health. Curr Atheroscler Rep 27(1):37","journal-title":"Curr Atheroscler Rep"},{"key":"3010_CR91","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ahj.2025.06.010","volume":"289","author":"M Hanif","year":"2015","unstructured":"Hanif M, Khan LA, Kulkarni A et al (2015) Global lipoprotein (a) testing trends from 2015 to 2023. Am Heart J 289:171\u2013179","journal-title":"Am Heart J"},{"key":"3010_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.101009","volume":"22","author":"M Ambrosio","year":"2025","unstructured":"Ambrosio M, Alebna PL, Lee T et al (2025) Performance of PREVENT and pooled cohort equations for predicting 10-year ASCVD risk in the UK Biobank. Am J Prev Cardiol 22:101009","journal-title":"Am J Prev Cardiol"},{"issue":"2","key":"3010_CR93","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","volume":"26","author":"N Stefan","year":"2017","unstructured":"Stefan N, Schick F, H\u00e4ring H-U (2017) Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab 26(2):292\u2013300","journal-title":"Cell Metab"},{"issue":"6","key":"3010_CR94","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/eurheartj\/ehp487","volume":"31","author":"A Romero-Corral","year":"2010","unstructured":"Romero-Corral A, Somers VK, Sierra-Johnson J et al (2010) Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 31(6):737\u2013746","journal-title":"Eur Heart J"},{"key":"3010_CR95","doi-asserted-by":"crossref","unstructured":"Coutinho T, Goel K,\u00a0Corr\u00eaa de S\u00e1\u00a0et al (2011) Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 57(19):1877\u20131886","DOI":"10.1016\/j.jacc.2010.11.058"},{"key":"3010_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002916","author":"C Chandramouli","year":"2019","unstructured":"Chandramouli C, Tay WT, Bamadhaj NS et al (2019) Association of obesity with heart failure outcomes in 11 Asian regions: a cohort study. PLoS Med. https:\/\/doi.org\/10.1371\/journal.pmed.1002916","journal-title":"PLoS Med"},{"issue":"4S","key":"3010_CR97","first-page":"S117","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105(4S):S117\u2013S314","journal-title":"Kidney Int"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-03010-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-026-03010-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-03010-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:03:43Z","timestamp":1788365023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-026-03010-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":97,"alternative-id":["3010"],"URL":"https:\/\/doi.org\/10.1007\/s00392-026-03010-5","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NHANES is approved by the National Center for Health Statistics Research Ethics Review Board, and all participants provided informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.Y.C. has received speaker\u2019s fees and research grants from Astra Zeneca, Abbott Technologies and Boston Scientific. N.W.S.C has received research grant support from National University Health System Seed Fund (NUHSRO\/2022\/RO5\u2009+\u20096\/Seed-Mar\/03), National Medical Research Council Research Training Fellowship (MH 095:003\/008\u2013303), National University of Singapore Yong Loo Lin School of Medicine's Academic Fellowship Scheme, and the National University Health System Clinician Scientist Program (NCSP2.0\/2024\/NUHS\/NCWS), CSDU Clinician-Scientist Grant, and the National Medical Research Council Transition Award (TA24jul-0008). M.S.K has received consulting fees from Novartis, Bayer, Boehringer Ingelheim and research support from Merck. ClR reports grants from the EU Innovative Medicine Initiative, Irish Research Council, Science Foundation Ireland, Anabio, and the Health Research Board. He serves on advisory boards and speakers panels of Novo Nordisk, Roche, Herbalife, Morphic Medical, Eli Lilly, Johnson & Johnson, Gila, Irish Life Health, Boehringer Ingelheim, Currax, Zealand Pharma, Keyron, AstraZeneca, Arrowhead Pharma, Amgen, AbbVie, Metsera, Nymble, Olympus, and Rhythm Pharma. ClR is the Chair of the Irish Society for Nutrition and Metabolism. ClR received stock options as payment for scientific advisory board functions from Metsera and Nymble. ClR provides obesity clinical care in the My Best Weight clinic and Beyond BMI clinic and is a co-owner of these clinics.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}